Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
362 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Ovarian Diseases" (362 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
3 Unknown  Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention:
4 Unknown  Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
Conditions: Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Other: medical chart review;   Other: study of socioeconomic and demographic variables;   Procedure: disease screening;   Procedure: evaluation of cancer risk factors;   Procedure: genitourinary surgical procedure;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
5 Recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Malignant Ovarian Mixed Epithelial Tumor;   Ovarian Brenner Tumor;   Ovarian Carcinosarcoma;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Serous Surface Papillary Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Ovarian Carcinoma
Interventions: Drug: WEE1 Inhibitor MK-1775;   Drug: Gemcitabine Hydrochloride;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
6 Recruiting Genetic Etiology in Premature Ovarian Insufficiency
Conditions: Primary Ovarian Insufficiency;   Genetic Predisposition to Disease
Intervention:
7 Not yet recruiting Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: everolimus and letrozole
8 Not yet recruiting Effect of Magnesium Supplementation on Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Dietary Supplement: Magnesium Oxide;   Dietary Supplement: Placebo
9 Recruiting Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm
Condition: Stage IIIC Ovarian Cancer
Interventions: Procedure: Laparoscopy;   Procedure: Cytoreduction
10 Unknown  Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women
Conditions: Menopause, Premature;   Hysterectomy;   Ovariectomy;   Estrogen Replacement Therapy;   Attitude;   Perception
Intervention: Procedure: Hysterectomy and Bilateral salpingo-oophorectomy
11 Not yet recruiting A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Subjects With Low CA125 Platinum-Sensitive Ovarian Cancer
Condition: Platinum-Sensitive Ovarian Cancer in First Relapse
Interventions: Drug: Farletuzumab;   Drug: Placebo
12 Unknown  Epidemiology of Ovarian Cancer in Taiwan
Condition: Ovarian Cancer
Intervention:
13 Recruiting Effect of Testosterone Treatment on Embryo Quality
Conditions: Primary Ovarian Insufficiency;   Female Infertility Due to Diminished Ovarian Reserve
Interventions: Drug: Testosterone cream (0.5mg per gram);   Dietary Supplement: DHEA;   Drug: Placebo
14 Unknown  Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction
Conditions: Hyperandrogenemia;   Obesity;   Polycystic Ovary Syndrome
Interventions: Drug: Hydrocortisone;   Drug: dexamethasone;   Drug: Cosyntropin;   Drug: r-hCG (Ovidrel)
15 Unknown  Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure
Condition: Premature Ovarian Failure,
Interventions: Biological: human umbilical cord mesenchymal stem cells;   Biological: hUCMSCs and hCBMNCs;   Biological: human cord blood mononuclear cells;   Drug: Hormone Replacement Therapy
16 Recruiting Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Conditions: Relapsed Epithelial Ovarian Cancer;   Relapsed Primary Peritoneal Cancer;   Relapsed Fallopian Tube Cancer
Interventions: Drug: Birinapant;   Drug: Conatumumab
17 Recruiting Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer
Conditions: Advanced Breast Carcinoma;   Advanced Ovarian Carcinoma
Intervention: Biological: ONT-10, Varlilumab combination
18 Recruiting Efficacy Study Comparing the Effect of Clomiphencitrate to an Antagonist Protocol
Conditions: Female Infertility;   Ovarian Insufficiency
Interventions: Drug: High Dose Clomiphencitrat;   Drug: Low Dose Clomiphencitrat;   Drug: High Dose Placebo;   Drug: Low dose Placebo
19 Unknown  Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy
Condition: Ovarian Carcinoma
Intervention: Drug: Cytophosphan, Celecoxib, Methotrexate
20 Recruiting Oxidative Stress and Bisphenol A (BPA) Impact With Polycystic Ovary Syndrome (PCOS)
Conditions: Oxidative Stress;   Endocrine Disrupting Chemicals;   Polycystic Ovary Syndrome
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years